SCD and cancer: With regard to lipid requirements, cancer cells have the capacity to switch from the uptake of fatty acids from the external medium (exogenous fatty acids) to the synthesis de novo of saturated fatty acids [5] that are converted into monounsaturated fatty acids thanks to the activity of the enzyme SCD1, which is commonly overexpressed in cancer cells [7].